(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/rkMx-xx_rPo/us-regeneron-sanofi-asthma-idINBRE94K0I020130521
TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced that its Luxid® for SharePoint 2013... ...http://in.advfn.com/p.php?pid=nmona&article=57662849
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of M... Intraday Stock... ...http://in.advfn.com/p.php?pid=nmona&article=57663084
The man charged with reviving France's shrinking economy and attracting businesses to invest there is gaining a reputation for doing the opposite.... ...http://www.sify.com/finance/does-france-have-right-plan-to-revive-its-economy-news-environment+and+nature-nfvpahgihbd.html
Posted by Equitymaster The principal shareholders must explain why the company is not pumping in more moneys into capex and why they are content... ...http://feeds.equitymaster.com/~r/TheOutsideView/~3/W08ywIuMdsU/detail.asp
Radisson Blu Hotel New Delhi Paschim...